This result is consistent with clinical evidence in post-COVID patients, where elevated IL-6 has been associated with myocardial damage and myocarditis, but without a clear relationship with other specific immune markers such as CD11d [46,48,49]. This evidence concerns the gene IL6 and myocarditis.